.jpg)
.png)
ORLANDO, Fla. — The interleukin (IL)-4 and IL-13 inhibitor dupilumab improved itch symptoms and curtailed disease activity while also reducing oral corticosteroid use in older patients with bullous pemphigoid (BP), a phase 2/3 study demonstrated. “Dupilumab demonstrated significant benefits across multiple disease aspects in BP at 36 weeks...
???? Are You a Music Artist Ready to Be Heard? ????
It’s time to stop playing around and get your music on real radio. Join a platform that truly supports artists and gives you the exposure you deserve.
SugarWaterRadio is changing the game—one song at a time.
Get real airplay, real listeners, and real results.
???? Submit your music now at SugarWaterRadio.com
Let’s make your dream a reality.
CLICK HERE & TURN UP YOUR FUTURE! ????
Copyright © 2023 swsports. All Rights Reserved
